Type 2 diabetes mellitus
Conditions
Sponsors
TAKEDA PHARMACEUTICAL COMPANY LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients who did not adequately respond to the following treatment •Treatment with sulfonylurea in addition to diet therapy and exercise therapy
Exclusion criteria
Exclusion criteria: Patients contraindicated for Nesina (1) Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus [these patients require prompt adjustment of hyperglycemia by fluid infusion and insulin, and hence use of Nesina is not appropriate.] (2) Patients with severe infection, pre- or post-operative patients, or patients with serious traumatic injury [blood glucose control by insulin injection is desirable for these patients, and hence use of Nesina is not appropriate.] (3) Patients with a history of hypersensitivity to any ingredient of Nesina
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse event (adverse reactions), HbA1c Frequency of adverse events (adverse reactions), HbA1c time profile Primary timeframe 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood glucose Changes in fasting blood glucose Secondary timeframe 12 months | — |
Outcome results
None listed